




Searching News Database: Rheos
HSMN NewsFeed - 23 Oct 2024
Alphina Therapeutics Appoints Veteran Biotech Executive, Nick Galli, as Chief Executive Officer
Alphina Therapeutics Appoints Veteran Biotech Executive, Nick Galli, as Chief Executive Officer
HSMN NewsFeed - 20 Dec 2018
Merck KGaA, Darmstadt, Germany, Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon
Merck KGaA, Darmstadt, Germany, Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon
HSMN NewsFeed - 2 Jun 2015
ZIOPHARM Announces Caesar J. Belbel, Chief Legal Officer, Appointed Chief Operating Officer
ZIOPHARM Announces Caesar J. Belbel, Chief Legal Officer, Appointed Chief Operating Officer
HSMN NewsFeed - 11 Dec 2014
CVRx(R) Granted CE Marking of the Barostim neo System(TM) for Conditional MRI Compatibility
CVRx(R) Granted CE Marking of the Barostim neo System(TM) for Conditional MRI Compatibility
HSMN NewsFeed - 7 Jan 2014
Barostim Therapy(TM) Projected to be Cost-Effective in Treating Resistant Hypertension
Barostim Therapy(TM) Projected to be Cost-Effective in Treating Resistant Hypertension
HSMN NewsFeed - 26 Mar 2013
ZIOPHARM Terminates Development of Palifosfamide in Metastatic Soft Tissue Sarcoma
ZIOPHARM Terminates Development of Palifosfamide in Metastatic Soft Tissue Sarcoma
HSMN NewsFeed - 28 Apr 2008
New Implantable Device Designed to Lower High Blood Pressure May Offer Hope for Millions of Patients
New Implantable Device Designed to Lower High Blood Pressure May Offer Hope for Millions of Patients
HSMN NewsFeed - 31 Oct 2007
CVRx(R), Inc. Receives CE Mark Approval for Rheos(R) Baroreflex Hypertension Therapy(TM) System
CVRx(R), Inc. Receives CE Mark Approval for Rheos(R) Baroreflex Hypertension Therapy(TM) System
HSMN NewsFeed - 11 Jul 2007
Medical Device Company CVRx Adopts Configurable ARC(R) Core For Implantable Blood Pressure Reduction Device
Medical Device Company CVRx Adopts Configurable ARC(R) Core For Implantable Blood Pressure Reduction Device
HSMN NewsFeed - 17 May 2007
CVRx(R), Inc. Appoints Todd Langevin Senior Vice President of Clinical and Commercial Development
CVRx(R), Inc. Appoints Todd Langevin Senior Vice President of Clinical and Commercial Development
HSMN NewsFeed - 16 Oct 2006
CVRx(R), Inc., Receives IDE Approval for Rheos(TM) Baroreflex Hypertension Therapy(TM) System Pivotal Trial
CVRx(R), Inc., Receives IDE Approval for Rheos(TM) Baroreflex Hypertension Therapy(TM) System Pivotal Trial
Additional items found! 2

Members Archive contains
2 additional stories matching:
Rheos
(Password required)
Rheos
(Password required)